🧬 Session 6: Medical Technologies in Translation at the 3rd Targeted Therapy Technologies Symposium (TTT25) features groundbreaking work at the intersection of biomedical engineering, diagnostics, implants, and therapeutic nanotechnologies.
This session highlights translational research and industry-academia collaborations driving real-world impact:
🎙 Prof. Murat Canpolat
MCC Medical & Akdeniz University
“Development of Biomedical Optics-Based Diagnostics Systems”
🎙 Mustafa Cüneyt Çıkman
BlooCell
“Personalized Biodegradable Implants: Current Status and Future Plans”
🎙 Tuğçe Karataş
RS Research
“Development of Receptor Targeted Nanoparticles”
🎙 Assoc. Prof. Ahmet Katı
Omica & University of Health Sciences
“Advanced In-Vitro Strategies for Targeted Therapy Development: Prioritizing Ethics and Translational Impact”
🎙 Milad Riazifar
Invitrx
“Therapeutic Potential of Engineered Extracellular Vesicles with Anti-Senescence Properties”
🎙 Prof. Ayhan Olcay
Innoway R&D Kft.
“Innovator Physician & Physician-Led Medtech Companies”
📅 Date: June 13, 2025
⏰ Time: 16:30–18:30
📍 Location: Fatin Gökmen Conference Hall, Boğaziçi University Kandilli Campus
👉 Event & registration: bogazicict3.net/
Join us to discover how breakthrough technologies are translated into impactful medical solutions.
#TTT25#Medtech#TranslationalMedicine#BiomedicalOptics#Implants#Nanoparticles#EthicsInScience#ExtracellularVesicles#Biotech#BoğaziçiCT3Symposium#CT3Innovation#HealthTechnologies
3rd Invitrx warning highlights broader FDA oversight weakness as the agency still founders on problem of 1000s of unproven US #stemcell clinic firms ipscell.com/2023/01/3rd-invi…@DrCaliff_FDA a new, strong approach is needed. People have been hurt & many more could be #stemcells
Having received warning letter in Feb 2017 and again in March 2020 (lnkd.in/gVjxgHDV) 'cell therapy', beauty product, and exosome company Invitrx (invitrx.com) has once again been hit with a warning letter (lnkd.in/gBigdEyV) foll…lnkd.in/grupSRgV
Health care professionals and consumers should report any adverse events related to treatments with Invitrx, stem cell or other cellular or tissue-based products to the FDA’s MedWatch Adverse Event Reporting program. go.usa.gov/xdzR7
Invitrx has also been warned about not following current good manufacturing practice requirements and current good tissue practice requirements, including deficient donor eligibility practices and inadequate contamination prevention.
FDA has sent a warning letter to Invitrx Therapeutics of Lake Forest, California for offering unapproved stem cell and other products that may put patients at risk. go.usa.gov/xdzDZ
On Tuesday, KGI students networked with more than 15 veteran and young professionals during a Biotech Regulatory Affairs Professionals Panel, featuring professionals from @EdwardsLifesci, @Invitrx, and Microvention-Terumo. #Networking#RegulatoryAffairs#GradSchool
#ad Today I received restorative stem cells from my good friend Greg DiRienzo @ProgenaCell. The stem cells were manufactured by Invitrx here in So Cal. My friend Dr Mathi Senapathi gave the cells to me intravenously. Is it possible to turn back the clock? I will let you know.